A syndrome of psychosis following discontinuation of an estrogen-progestogen contraceptive and improvement following replacement: A case report

Neuropsychobiology

Volumn 40, Issue 2, 1999, Pages 75-77

  Huber, T J ^a   Nickel, V ^b   Troger M ^b   Schneider, U ^b   Husstedt, H ^b   Emrich, H M ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NONE

Author keywords

Estrogen; Estrogen progestogen contraceptive; Estrogen progestogen substitution; Hormone replacement therapy; Hormone withdrawal psychosis; Progestogen; Psychosis; Self mutilation; Self inflicted injury

Indexed keywords

CONTRACEPTIVE AGENT; ESTROGEN; GESTAGEN;

ADULT; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; FEMALE; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; ODONTOID PROCESS FRACTURE; PRIORITY JOURNAL; PSYCHOSIS; SPINAL CORD INJURY;

ADULT; ANTIPSYCHOTIC AGENTS; CONTRACEPTIVES, ORAL, COMBINED; DRUG THERAPY, COMBINATION; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; HYPOGONADISM; PSYCHOTIC DISORDERS; SELF MUTILATION; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME;

EID: 0032872550     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026601     Document Type: Article

References (18)

1. Riecher-Rössler A, Häfner H, Maurer K, Sturmbaum M, Schmidt R: Schizophrenia symptomatology varies with serum estradiol levels during menstrual cycle. Schizophr Res 1992;6:114-115.
2. Dose M. Apelt S, Emrich HM: Carbamazepin as an adjunct of antipsychotic therapy. Psychiatry Res 1987;22:303-310.
3. Huber G: Körperlich begründbare Psychosen: in Huber G (ed): Psychiatrie: Lehrbuch für Studierende und Ärzte. Stuttgart, Schattauer, 1994, pp 96-100.
4. Lovestone S: Periodic psychosis associated with the menstrual cycle and increased blink rate. Br J Psychiatry 1992;161:402-404.
5. A receptors. J Neuroendocrinol 1995;7:171-177.
6. Busatto GF, Pilowsky LS, Costa DC, Ell PJ, David AS, Lucey JV, Kerwin RW: Correlation between reduced in vivo benzodiazepine receptor binding and severity of psychotic symptoms in schizophrenia. Am J Psychiatry 1997;154: 56-63.
7. Weinberger DR: The biological basis of schizophrenia: New directions. J Clin Psychiatry 1997;58(suppl 10):22-27.
8. Seeman MV: Clinical and demographic correlates of neuroleptic response. Can J Psychiatry 1985;30:243-245.
9. Kopala LC, Lewine R, Good KP, Fluker M, Martzke JS, Lapointe JS, Honer WG: Clinical features of schizophrenia in a woman with hyperandrogenism. J Psychiatry Neurosci 1997;22:56-60.
10. Seeman MV: The role of estrogen in schizophrenia. J Psychiatry Neurosci 1996;21:123-127.
11. Sichel DA, Cohen LS, Robertson LM, Ruttenbergh A, Rosenbaum JF: Prophylactic estrogen in recurrent postpartum affective disorder. Biol Psychiatry 1995;38:814-818.
12. Oades RD, Schepker R: Serum gonadal steroid hormones in young schizophrenic patients. Psychoneuroendocrinology 1994;19:373-385.
13. Winchel RM, Stanley M: Self-injurious behavior: A review of the behavior and biology of self-mutilation. Am J Psychiatry 1991;148: 306-317.
14. Conacher GN: Isolated but serious acts of self-mutilation. Am J Psychiatry 1993;150:172-173.
15. Okamura H, Murakami T, Yokoyama C, Nakamura T, Ibata Y: Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rats. II. Intracerebral microinjection of dopamine agonists and antagonists. J Pharmacol Exp Ther 1997;280: 1031-1037.
16. Yokoyama C, Okamura H: Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat. I. Dopaminergic neurons and receptors. J Pharmacol Exp Ther 1997;280:1016-1030.
17. Prestar FJ, Keidel M: Paralysis cruciata - Ein seltenes Hirnstammläsionssyndrom nach HWS-Trauma. Nervenarzt 1993;64:396-400.
18. Levi AD, Tator CH, Bunge RP: Clinical syndromes associated with disproportionate weakness of the upper versus the lower extremities after cervical spinal cord injury. Neurosurgery 1996;38:179-185.